Untitled item
S5W-20173 · Written Question · lodged by Findlay, Neil
The answer
Although some assurances were received in the agency’s response, the Chief Medical Officer has written again to the MHRA. Aside from asking the MHRA to set out the actions it has taken specifically in relation to transvaginal mesh, the Chief Medical Officer also outlined a number of more general concerns, including in relation to the governance of notified bodies, the MHRA’s relationship with industry, and public confidence in the agency and the regulatory system.
Details are provided in a Scottish Government news release of 27 November: www.gov.scot/news/regulation-of-mesh-devices .
Answered by Jeane Freeman on 21 Dec 2018.